I (2000-2009)

*older Articles in Pre-2000 List

IBS / IBD (See Also BOWEL DISORDERS)
IBUPROFEN (Blocks Breakdown of Anandamide which Actually Relieves Pain)
IDIOPATHIC INTRACRANIAL HYPERTENSION
IDRASIL (‘Natural Phytocannabinoid’ Pill, Available in California by Dr Recommendation)
IMMUNE SYSTEM*
INCONTINENCE (See BLADDER)
INDICATIONS AND CLINICAL USES*
INFLAMMATION*
INFLUENZA (See FLU / INFLUENZA)
INJURIES (See WOUNDS AND INJURIES)
INTERACTIONS WITH OTHER DRUGS*
ISAACS’ SYNDROME / ACQUIRED NEUROMYOTONIA
IQ / MEMORY / COGNITIVE EFFECTS*
ITCH (See PRURITIS)


IBS / IBD
MARIJUANA AND IRRITABLE BOWEL SYNDROME (IBS) (anecdotal-undated) http://www.rxmarihuana.com/christine.htm
Endometriosis by Kim (anecdotal–undated) http://rxmarijuana.com/shared_comments/Endometriosis.htm
Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation (full-2004) http://ajpgi.physiology.org/cgi/content/full/287/1/G7
Involvement of cannabinoid receptors in gut motility and visceral perception (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574910/
Fibromyalgia, IBS, and the Endocannabinoid-CB-Receptor (ECBR) system (abst-2004) http://www.prohealth.com//library/showArticle.cfm?libid=10562
Peripheral, but not central effects of cannabidiol derivatives: Mediation by CB 1 and unidentified receptors (full-2005) http://www.researchgate.net/publication/7830541_Peripheral_but_not_central_effects_of_cannabidiol_derivatives_mediation_by_CB%281%29_and_unidentified_receptors
Cannabinoids and the digestive tract (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16596788
The pathophysiologic rationale for biological therapies in inflammatory bowel disease (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15930983
Cannabis-based drugs could offer new hope for inflammatory bowel disease patients (news-2005) http://www.medicalnewstoday.com/articles/28584.php
Potential new target for cannabis-derived drugs as a treatment of inflammatory bowel disease (news–2005) http://www.news-medical.net/news/2005/08/02/12175.aspx
Inflammatory Bowel Disease May Respond To Cannabis-Derived Drugs (news–2005) http://www.medpagetoday.com/Gastroenterology/InflammatoryBowelDisease/1548
Endocannabinoids and the gastrointestinal tract (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16751708
top
The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2008.01175.x/full
Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01674.x/full
Cannabinoids and gastrointestinal motility: animal and human studies (link to PDF-2008) http://www.europeanreview.org/article/519
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18404144
The role of fatty acid hydrolase gene variants in inflammatory bowel disease (full–2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2008.03910.x/pdf
BENEFICIAL EFFECT OF AN ORAL CANNABINOID IN PATIENTS WITH IBS (abst–2009) http://www.efic-congress.org/showabstract.php?abstract=696
Cannabis Hope for Inflammatory Bowel Disease (news–2009) http://www.sciencedaily.com/releases/2009/12/091220175502.htm
Alternatives: Miracle Marijuana (anecdotal/news–2009) http://www.heretohelp.bc.ca/visions/cannabis-vol5/alternatives


IBUPROFEN
Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase (full–2000) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572338/
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572815/
Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12751821
Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extrabut not intracellular pH (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12644895
Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides? (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/17027744
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16480822
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16442133
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/17397826


IDIOPATHIC INTRACRANIAL HYPERTENSION
Dronabinol reduces signs and symptoms of idiopathic intracranial hypertension : a case report (abst-2006) http://www.liebertonline.com/doi/abs/10.1089/jop.2006.22.68
top
Science: Cannabis and THC effective in the treatment of idiopathic intracranial hypertension (news–2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=213#1


IDRASIL
Introducing Idrasil – The Marijuana Pill (ad–undated) http://idrasil.info/


IMMUNE SYSTEM
Cannabinoids, immune system and cytokine network (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/16918439
Immunomodulation by Cannabinoids is Absent in Mice Deficient for the Cannabinoid Cb(2) Receptor (abst–2000) http://www.sciencedirect.com/science/article/pii/S0014299900002119
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells (full–2002) http://www.fasebj.org/cgi/content/full/15/12/2171?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=10&sortspec=relevance&resourcetype=HWCIT
Endocannabinoids in the immune system and cancer (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12052046
Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells (full–2003) http://www.jimmunol.org/content/170/10/4953.full?sid=590f7819-f39b-4214-abca-07231b51da55
The cannabinoid system and immune modulation (full–2003) http://www.jleukbio.org/content/74/4/486.full.pdf+html
Cannabis May Suppress Immune System (news–2003) http://lupus.webmd.com/news/20030415/cannabis-may-suppress-immune-system
The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation (full–2004) http://ar.iiarjournals.org/content/28/6A/3743.long
The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2 (full–2004) http://www.jleukbio.org/content/76/4/854.long
Cannabinoids and the immune system. Of men, mice and cells (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15221424
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance (full-2005) http://www.jleukbio.org/content/78/6/1192.long
Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders (full-2005) http://www.jleukbio.org/content/78/1/231.long
CB2 cannabinoid receptor agonist, JWH-015 triggers apoptosis in immune cells: Potential role for CB2 selective ligands as immunosuppressive agents (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1864948/
Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor (full-2006) http://molpharm.aspetjournals.org/content/70/1/41.long
Formation of B and T cell subsets require the cannabinoid receptor CB2 (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16924491
Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells (abst-2006) http://link.springer.com/article/10.1007%2Fs11481-005-9007-x
top
CB2 receptors in the brain: role in central immune function (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219530/?tool=pmcentrez
Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2083705/?tool=pubmed
Targeting astrocytomas and invading immune cells with cannabinoids: a promising therapeutic avenue (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17952648
The Endocannabinoids: Functional Roles and Therapeutic Opportunities (news–2007) http://www.alphagalileo.org/ViewItem.aspx?ItemId=11344&CultureCode=en
Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain (full–2008) http://www.jneurosci.org/cgi/content/full/28/46/12125
Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376822/?tool=pmcentrez
The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677557/
Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis (full–2008) http://www.jni-journal.com/article/S0165-5728%2807%2900396-7/fulltext
Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation (full-2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01674.x/full
Endocannabinoids and the brain immune system: new neurones at the horizon? (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01672.x/full
Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18275004
Initial study of Hemp seeds protein on antifatigue and the immunomodulation effects in mice (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18589601
Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768535/?tool=pmcentrez
top
Cannabinoids as novel anti-inflammatory drugs (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/?tool=pubmed
Cannabidiol-induced lymphopenia does not involve NKT and NK cells (full-2009) http://www.jpp.krakow.pl/journal/archive/10_09_s3/pdf/99_10_09_s3_article.pdf
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats (full–2009) http://jn.nutrition.org/content/139/8/1495.long
Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768754/
Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795513/
top
CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/18792785
The morphology of the immune system in opiomania, cannabism, and polynarcotism (abst-2009) http://www.unboundmedicine.com/medline/ebm/record/19938701/full_citation/%5BThe_morphology_of_the_immune_system_in_opiomania_cannabism_and_polynarcotism%5D
Cannabinoid Receptors and Corneal Epithelium Repair (abst–2009) http://iovs.arvojournals.org/article.aspx?articleid=2368655&resultClick=1
Cannabinoids produced in the human body have an anti-inflammatory effect (news-2009)  http://www.alphagalileo.org/ViewItem.aspx?ItemId=14530&CultureCode=en


INDICATIONS AND CLINCAL USES
Therapeutic aspects of cannabis and cannabinoids (full–2001) http://bjp.rcpsych.org/cgi/content/full/178/2/107
Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential Chapter 11 Review of Therapeutic Effects (book excerpt–2002) http://books.google.com/books?id=JvIyVk2IL_sC&pg=PA123#v=onepage&q&f=false
Pharmacokinetics and pharmacodynamics of cannabinoids (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12648025
Therapeutic potential of cannabinoids in CNS disease (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12617697
“Dr. Tod’s List” – Chronic Conditions Treated With Cannabis (full–2004) (The inspiration for this List!) http://www.letfreedomgrow.com/cmu/DrTodHMikuriya_list.htm
Potential Merits of Cannabinoids for Medical Uses – Robert J. Meyer, M.D (testimony-2004) http://www.fda.gov/NewsEvents/Testimony/ucm114741.htm
Marijuana-Like Compounds May Aid Array Of Debiliatiing Conditions Ranging From Parkinson’s Disease To Pain (news–2004) http://www.sciencedaily.com/releases/2004/10/041027102621.htm
Survey of Australians using cannabis for medical purposes (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1262744/?tool=pmcentrez
Older Americans Have Stake in Medical Marijuana Struggle (news-2005) http://entheology.com/news-articles/older-americans-have-stake-in-medical-marijuana-struggle/
Cannabinoids In Medicine: A Review Of Their Therapeutic Potential (full-2006) http://www.doctordeluca.com/Library/WOD/WPS3-MedMj/CannabinoidsMedMetaAnalysis06.pdf
Cannabinoids in health and disease (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202504/
Pharmacological actions and therapeutic uses of cannabis and cannabinoids (full-2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2044.2001.02269.x/full
Medical Use of Cannabis (marijuana) (news-2009) http://www.heretohelp.bc.ca/factsheet/medical-use-of-cannabis
top


INFLAMMATION
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11106791
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat (full-2002) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1573125&tool=pmcentrez
Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors (full–2003) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1943189
Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/14644587
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation (full-2004)
https://www.jstage.jst.go.jp/article/jphs/96/4/96_4_367/_pdf
Cannabinoids and neuroinflammation (full-2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574256/?tool=pmcentrez
Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation (full-2004) http://ajpgi.physiology.org/cgi/content/full/287/1/G7
A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis (full-2004)
http://onlinelibrary.wiley.com/doi/10.1002/art.20050/full
The gastrointestinal pharmacology of cannabinoids: an update (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15525546
Cannabinoids spell relief in colon inflammation (news–2004) http://www.mpg.de/496761/pressRelease20040506?filter_order=L
The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues (full–2005) https://www.jstage.jst.go.jp/article/jphs/98/1/98_1_77/_pdf
Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751505/?tool=pubmed
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation (link to PDF–2005) http://www.springerlink.com/content/tq777102q4185073/fulltext.html
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease (abst-2005) http://www.ncbi.nlm.nih.gov/pubmed/15837565?dopt=Abstract
Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16103691
Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430692/?tool=pubmed
Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice (full–2006) http://www.jimmunol.org/content/177/12/8796.full
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells (full–2006)
http://www.sciencedirect.com/science/article/pii/S0896627305010081
Endocannabinoids and the gastrointestinal tract (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16751708
Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells (abst–2006) http://link.springer.com/article/10.1007%2Fs11481-005-9007-x
top
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190014/?tool=pubmed
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis (full-2007) http://www.jleukbio.org/cgi/content/full/82/6/1382
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression (Alzheimer’s) (full-2007) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2189818&tool=pmcentrez
Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence (full-2007)
http://jpet.aspetjournals.org/content/322/3/1144.long
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro (full-2007)
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2189767&tool=pmcentrez
Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis (full–2007) http://www.jimmunol.org/content/179/2/753.long
Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation (full-2007) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1852513&tool=pmcentrez
Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis (full-2007) http://www.jleukbio.org/cgi/reprint/82/3/532?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=240&resourcetype=HWCIT
The endocannabinoid system in targeting inflammatory neurodegenerative diseases (full-2007) http://www.academia.edu/5172933/The_endocannabinoid_system_in_targeting_inflammatory_neurodegenerative_diseases
Actions of N-arachidonyl-glycine in a rat inflammatory pain model (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042976/
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219541/?tool=pmcentrez
Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher (interview-2007) http://www.jleukbio.org/cgi/content/full/82/6/1390?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=880&resourcetype=HWCIT
Cannabinoids and neuroprotection in motor-related disorders (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/18220777
Cannabis tinctures and extracts – in vitro profiling for cytotoxic and anti-inflammatory effects (abst–2007) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2007-986840
Cannabinoids for the treatment of inflammation (abst-2007) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=17520866&dopt=abstractplus
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/12749972
Constituents Of Hashish And Marijuana May Help To Fight Inflammation And Allergies (news-2007) http://www.sciencedaily.com/releases/2007/06/070607171120.htm
Pot Chemical May Curb Inflammation (news–2007) http://www.webmd.com/allergies/news/20070607/pot-chemical-may-curb-inflammation
Endocannabinoids appear to play important role in regulating inflammation (news-2007) http://www.news-medical.net/news/2007/06/08/26114.aspx
top
Hippies vindicated: Human-produced cannabinoids have anti-inflammatory powers (news–2007) http://www.sciencecodex.com/hippies_vindicated_human_produced_cannabinoids_have_anti_inflammatory_powers
Anti-inflammatory cannabinoids in diet (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633791/?tool=pmcentrez
Cannabinoid receptors in acute and chronic complications of atherosclerosis (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219535/?tool=pmcentrez
Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586121/?tool=pubmed
Inflammation and aging: can endocannabinoids help? (full-2008) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2408719&tool=pmcentrez
Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01674.x/full
Cannabinoid CB2 receptors in human brain inflammation (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219537/
Evaluation of fatty acid amides in the carrageenan-induced paw edema model (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200792/
Cannabinoid Modulation of Cutaneous A{delta} Nociceptors During Inflammation (full-2008) http://jn.physiology.org/cgi/reprint/100/5/2794
Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585399/?tool=pubmed
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2 (full–2008) http://molpharm.aspetjournals.org/content/73/2/441.long
Cannabinoids as therapeutic agents for ablating neuroinflammatory disease (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750822/
Endocannabinoids and the brain immune system: new neurones at the horizon? (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01672.x/full
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders (abst-2008) http://www.unboundmedicine.com/medline/ebm/record/18844286/abstract/Cannabidiol_in_medicine:_a_review_of_its_therapeutic_potential_in_CNS_disorders_
Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18840450
Discovery of a novel cannabinoid in food (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0028-1083900
Cannabinoids in the control of pain (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/19388223
Scientists are High on Idea that Cannabis Reduces Memory Impairment (news-2008) http://www.physorg.com/news146320102.html
Why Cannabis Stems Inflammation (news-2008) http://www.sciencedaily.com/releases/2008/07/080720222549.htm
Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768535/?tool=pmcentrez
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688760/?tool=pubmed
top
Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells (full–2009) http://www.jbc.org/content/285/3/1616.full?sid=43211ca4-a4aa-4182-a554-d15e2835e288
Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous
proresolving and anti-inflammatory eicosanoid, lipoxin A4 (full-2009) http://www.fasebj.org/cgi/content/full/23/5/1503?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=2400&resourcetype=HWCIT
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats (full–2009) http://jn.nutrition.org/content/139/8/1495.long
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative / Nitrosative Stress, Inflammation, and Cell Death (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682269/
Cannabinoids as novel anti-inflammatory drugs (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/?tool=pubmed
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664885/?tool=pmcentrez
Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work? (full–2009) http://cardiovascres.oxfordjournals.org/content/84/3/341.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Opposite effects of anandamide and n-arachidonoyl dopamine in the regulation of prostaglandin E2 and 8-iso-PGF2α formation in primary glial cells (full–2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.05966.x/full
Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system (full–2009) http://stroke.ahajournals.org/content/40/6/2157.long
The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function (abst–2009) http://content.karger.com/produktedb/produkte.asp?DOI=000201556&typ=pdf
Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and proinflammatory cytokines during experimental periodontitis in rats (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19070683
Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19385063
Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19409856
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19095868
Cannabinoids produced in the human body have an anti-inflammatory effect (news–2009) http://www.alphagalileo.org/ViewItem.aspx?ItemId=14530&CultureCode=en
top


INTERACTIONS WITH OTHER DRUGS
Involvement of central and peripheral cannabinoid receptors in the regulation of heart resistance to arrhythmogenic effects of epinephrine (abst–2000) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11182823&dopt=abstractplus
Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11828716
Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration (full–2002) http://jpet.aspetjournals.org/content/303/1/340.long
Tobacco and Cannabis Smoking Cessation Can Lead to Intoxication with Clozapine or Olanzapine (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/11981356
Nursing Home Residents Test Positive For Marijuana (news–2002) http://www.cleartest.com/news/nursing-home-residents-test-positive-for-marijuana/
Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574061/?tool=pubmed
Cannabis reduces opioid dose in the treatment of chronic non-cancer pain (full-2003) http://www.jpsmjournal.com/article/S0885-3924(03)00142-8/fulltext
Manipulation of the endocannabinoid system by a general anaesthetic (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573927/?tool=pubmed
Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol (full–2003) http://jpet.aspetjournals.org/content/305/3/812.long
Therapeutic potential of cannabis (full–2003) http://www.ufcw770.org/sites/all/themes/danland/files/TherapeuticPotentialOfCannabis.pdf
Topical cannabinoid enhances topical morphine antinociception (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/14499448
Cannabis Abuse is Not a Risk Factor for Treatment Outcome in Methadone Maintenance Treatment: a 1-year Prospective Study in an Israeli Clinic (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14731193
Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (“Ecstasy”) in rats (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15081792
Influence of medicinal cannabis (MC) on the pharmacokinetics (PK) of docetaxel (DOC) and irinotecan (CPT-11) (abst–2005) http://www.aacrmeetingabstracts.org/cgi/content/abstract/2005/1/938-c?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=1840&resourcetype=HWCIT
Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol (abst-2005) http://www.ncbi.nlm.nih.gov/pubmed/16288738
Effects of general anesthesia on anandamide blood levels in humans (full–2006) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1923152&resultClick=3
Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2 (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16956707
top
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16480822
Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain – a randomized controlled trial (abst–2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=197
Cannabinoid–improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB1 receptor (abst–2006) http://www.sciencedirect.com/science/article/pii/S0014299906008855
Arachidonyl-2′-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock induced seizure model (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16930590
Cannabinoids Enhance Analgesic Effects Of Anti-Inflammatory Drugs, Study Says (news-2006) http://www.norml.org/index.cfm?Group_ID=6819
Opioid Antagonism of Cannabinoid Effects: Differences between Marijuana Smokers and Nonmarijuana Smokers (full–2007) http://www.nature.com/npp/journal/v32/n6/abs/1301243a.html
Low dose combination of morphine and Δ9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040345/
Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel (full-2007) http://theoncologist.alphamedpress.org/cgi/content/full/12/3/291
Antinociceptive Synergy Between the Cannabinoid Receptor Agonist WIN 55,212-2 and Bupivacaine in the Rat Formalin Test (full–2007) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2007/03000/Antinociceptive_Synergy_Between_the_Cannabinoid.50.aspx
The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190019/?tool=pubmed
Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190028/?tool=pubmed
Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17520319
Additive Effects of Timolol and Cannabinoids on Intraocular Pressure in a Rat Glaucoma Model (abst–2007) http://abstracts.iovs.org/cgi/content/abstract/48/5/4807?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=560&resourcetype=HWCIT
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting (abst–2007) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=191
Synergy between Delta(9)-tetrahydrocannabinol and morphine in the arthritic rat (abst–2007) http://www.unboundmedicine.com/medline/ebm/record/17498686/abstract/Synergy_between_Delta_9__tetrahydrocannabinol_and_morphine_in_the_arthritic_rat
Science: The use of cannabis does not influence the efficacy of two anti-cancer drugs, a clinical study finds (news – 2007) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=242#2
Repeated Cannabinoid Injections into the Rat Periaqueductal Gray Enhances Subsequent Morphine Antinociception (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743428/?tool=pmcentrez
top
Priapism, ecstasy, and marijuana: is there a connection? (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441841/?tool=pubmed
Additive Interaction of the Cannabinoid Receptor I Agonist Arachidonyl-2-chloroethylamide with Etomidate in a Sedation Model in Mice (full–2008) http://journals.lww.com/anesthesiology/Fulltext/2008/04000/Additive_Interaction_of_the_Cannabinoid_Receptor_I.19.aspx
Propofol Sedation Is Reduced by {Delta}9-Tetrahydrocannabinol in Mice (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18635473
Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1) (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18619955
Enhancing the in vitro cytotoxic activity of Δ9-tetrahydrocannabinol in leukemic cells through a combinatorial approach (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18608861
Latest cannabis contamination – homosildenafil and thiohomosildenafil (AKA Viagra) (news-2008) http://ukcia.org/wordpress/?p=39
Effects of Cannabinoids on Caffeine Contractures in Slow and Fast Skeletal Muscle Fibers of the Frog (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697372/?tool=pmcentrez
Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain (full–2009) http://www.molecularpain.com/content/5/1/35
Dose Dependent effects of Celecoxib on CB-1 Agonist Induced Antinociception in mice (full-2009) http://journals.tums.ac.ir/upload_files/pdf/_/14234.pdf
Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550403/pdf/13181_2009_Article_BF03178273.pdf
Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil (abst–2009) http://www.springerlink.com/content/45008p9643k139l4/
Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19394652
Cannabis Coadministration Potentiates the Effects of “Ecstasy” on Heart Rate and Temperature in Humans (abst-2009) http://www.unboundmedicine.com/medline/ebm/record/19440186/abstract/Cannabis_Coadministration_Potentiates_the_Effects_of_%22Ecstasy%22_on_Heart_Rate_and_Temperature_in_Humans_
Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/18989636
Induction dose of propofol in patients using cannabis (abst-2009) http://www.unboundmedicine.com/medline/ebm/record/19237981/abstract/Induction_dose_of_propofol_in_patients_using_cannabis_
Cannabinoids, Opioids and MDMA: Neuropsychological Interactions Related to Addiction (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/20017726?dopt=Abstract
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects (abst–2009) http://www.frontiersin.org/publications/19027757
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania (abst–2009) http://jop.sagepub.com/content/25/2/274.abstract
An unusual cause of syncope (abst–2009) http://casereports.bmj.com/content/2009/bcr.09.2009.2282.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=320&sortspec=date&resourcetype=HWCIT
top
Interaction of the cannabinoid and opioid systems in the modulation of nociception (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19367508?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=34
Smoking Pot, Cigarettes Ups COPD Risk (news–2009) http://www.webmd.com/news/20090413/smoking-pot-cigarettes-ups-copd-risk


ISAACS’ SYNDROME / ACQUIRED NEUROMYOTONIA
Cannabinoids affect dendritic cell (DC) potassium channel function and modulate DC T cell stimulatory capacity (full–2008) http://www.jimmunol.org/content/181/5/3057.long


IQ / MEMORY / COGNITIVE EFFECTS
Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10762668
Neuropsychological Performance in Long-term Cannabis Users (full–2001) http://archpsyc.amaassn.org/cgi/content/full/58/10/909?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=2880&resourcetype=HWCIT
Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults (full-2002) http://www.cmaj.ca/cgi/content/full/166/7/887
Cognitive Measures in Long-term Cannabis Users (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12412835
Heavy cannabis use without long-term effect on global intelligence (news–2002) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=115#2
Marijuana does not dent IQ permanently (news-2002) (may need registration) http://www.newscientist.com/article/dn2140-marijuana-does-not-dent-iq-permanently.html
CANNABINOIDS ALTER RECOGNITION MEMORY IN RATS (full–2003) http://www.if-pan.krakow.pl/pjp/pdf/2003/5_903.pdf
Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study (full-2003) http://www.ukcia.org/research/NonacuteNeurocognitiveEffectsMetaAnalysis.pdf
Study: Brain Not Permanently Damaged by Marijuana (news–2003) http://www.drugfree.org/join-together/drugs/study-brain-not-permanently
Minimal Long-Term Effects Of Marijuana Use Found In Central Nervous System By UCSD Researchers (news–2003) http://www.sciencedaily.com/releases/2003/06/030630112652.htm
Differential Effects of THC or CBD-rich Cannabis Extracts on Working Memory in Rats (full-2004) http://www.ukcia.org/research/THCCBDWorkingMemory.pdf
Marijuana Effects On Human Forgetting Functions (full–2005) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1193701&tool=pmcentrez
Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1266095/?tool=pubmed
Drug-related decrease in neuropsychological functions of abstinent drug users (link to PDF-2005) http://www.eurekaselect.com/94427/article
Long-term effects of exposure to cannabis (abst–2005) http://www.sciencedirect.com/science/article/pii/S1471489204001973
top
Neurocognitive consequences of marihuana–a comparison with pre-drug performance (abst-2005) http://marijuana.researchtoday.net/archive/2/2/22.htm
Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15763177
Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats (abst–2005) http://www.sciencedirect.com/science/article/pii/S1074742704001182
‘Info-mania’ dents IQ more than marijuana (news–2005) http://news.bio-medicine.org/?q=medicine-news/e-mail-affects-brain-more-than-marijuana–4194
Regulation of adult neurogenesis by cannabinoids (abst–2006) http://cat.inist.fr/?aModele=afficheN&cpsidt=18227851
Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase (full-2007) http://www.fasebj.org/content/21/10/2431.full
The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013991/
Cerebellar-Dependent Learning as a Neurobehavioral Index of the Cannabinoid System (abst–2007) http://dl.begellhouse.com/journals/7b004699754c9fe6,64ecdd6045552415,684ce6ce63101f0f.html
Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users (abst–2007) http://www.informaworld.com/smpp/content~content=a778611568~db=all
Neuropharmacological effects of oleamide in male and female mice (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17588682
Cannabis Intoxication Does Not Adversely Impact Decision Making (news-2007) http://www.illinoisnorml.org/content/view/558/27/
The cannabinoid CB1 receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577903/?tool=pmcentrez
Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis (full–2008) http://www.nature.com/npp/journal/v33/n10/full/1301643a.html
Multiple sclerosis, cannabinoids, and cognition (full–2008) http://neuro.psychiatryonline.org/article.aspx?articleid=103259
Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users (abst–2008) http://www.unboundmedicine.com/medline/ebm/record/18719045/full_citation/Neurocognitive_performance_during_acute_THC_intoxication_in_heavy_and_occasional_cannabis_users_
Review: executive functioning and cannabis use (abst–2008) http://www.unboundmedicine.com/medline/ebm/record/18373021/abstract/%5BReview:_executive_functioning_and_cannabis_use_%5D
Fat-induced satiety factor oleoylethanolamide enhances memory consolidation (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683095/?tool=pubmed
Marijuana Primes, Marijuana Expectancies, and Arithmetic Efficiency (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670744/?tool=pmcentrez
Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660732/?tool=pmcentrez
top
Opposite Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055598/pdf/npp2009184a.pdf
Is moderate substance use associated with altered executive functioning in a population based sample of young adults? (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19946940/full_citation/Is_moderate_substance_use_associated_with_altered_executive_functioning_in_a_population_based_sample_of_young_adults
Roles of the endocannabinoid system in learning and memory (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/21104385